SAN MATEO, Calif., June 3, 2010 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management will present at the Jefferies Global Life Sciences Conference in New York City on Tuesday, June 8 th at 4:00 p.m. Eastern Time.

The presentation will be webcast live and may be accessed from the home page of Pain Therapeutics' website at A replay of the webcast will continue to be available on the website for up to 90 days.

About Pain Therapeutics, Inc.

Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In addition to REMOXY ®, a unique abuse-resistant controlled-release oxycodone, the company has three drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and PTI-721. Pain Therapeutics is also working on a new treatment for patients with hemophilia.
CONTACT:  Pain Therapeutics, Inc.          Judy Ishida, Administrative Manager          650-645-1924